Atlas Trials

A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma

Clinical trial NCT00369512 · COMPLETED

Trial details

NCT number
NCT00369512
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2006-08-01
Primary completion
2012-01-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.